BioNTech Initiates Phase 1 Clinical Trial for Malaria
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel multi-antigen vaccine approachFirst evaluated candidate...
Source: globenewswire.com
Stay updated with breaking news from Frika Cdc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel multi-antigen vaccine approachFirst evaluated candidate...